Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|February 2, 2013
Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemiaShinichi Kako, Heiwa Kanamori, Naoki Kobayashi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 27, 2018
Disseminated fusariosis emerged from prolonged local genital infection after cord blood transplantationKohei Okada, Tomoyuki Endo, Daigo Hashimoto, et al.
Case Reports in Hematology|April 2, 2016
Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to ChemotherapyKohei Kasahara, Masahiro Onozawa, Naohiro Miyashita, et al.
International Journal of Hematology|February 16, 2017
Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell TransplantationAkio Shigematsu, Shinichi Kako, Kenjiro Mitsuhashi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effectSouichi Shiratori, Atsushi Yasumoto, Junji Tanaka, et al.
American Journal of Hematology|October 7, 2017
Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adultsYasuyuki Arai, Tadakazu Kondo, Akio Shigematsu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemiaAkio Shigematsu, Takeshi Kondo, Satoshi Yamamoto, et al.
International Journal of Hematology|January 21, 2010
Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantationTakeshi Kondo, Atsushi Yasumoto, Kotaro Arita, et al.
International Journal of Hematology|March 20, 2026
Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in JapanFumiaki Fujii, Masahiro Onozawa, Shota Yoshida, et al.
International Journal of Hematology|July 2, 2013
A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study GroupYoshihiro Torimoto, Kazuya Sato, Katsuya Ikuta, et al.
Pageof 10